JEFFERSON CITY, Mo., March 31, 2016 -- The Board of Hitec Corp. (OTC Pink:HTIC) (PINKSHEETS:HTIC) (the “Company”) today announces the resignation of Director Jeffrey Michel.
The Board of Directors has accepted the resignation of Jeffrey Michel. Mr. Michel has resigned to pursue other business interests.
Harvey Buhr, Chairman stated, “It is with regret we accept the resignation of Jeff. He has served the Company and shareholders of Hitec with great diligence and care. We wish him well in his future pursuits.”
Hitec Corp. is a publicly held company engaged in the business of off the road tire (OTR) pyrolysis processing.
Safe Harbor Statement
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plan, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT: Douglas Castle Global Edge International Email: [email protected]


NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 



